2ANT - JenaLib

Asymmetric Unit (85, 166)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	I/L	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	I/L	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	I/L	R	24	C
05	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	I/L	R	47	C
06	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	I/L	R	47	H
07	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	I/L	R	47	S
08	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	I/L	R	57	C
09	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	58	L
10	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	63	C
11	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	63	S
12	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	66	P
13	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	80	T
14	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	89	K
15	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	I/L	G	93	D
16	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	I/L	C	95	R
17	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	I/L	L	99	F
18	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	99	V
19	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	Q	101	K
20	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	I/L	K	114	E
21	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	I/L	T	115	A
22	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	I/L	S	116	P
23	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	I/L	Q	118	P
24	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	I/L	H	120	Y
25	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	126	P
26	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	128	Y
27	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	I/L	R	129	Q
28	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	I/L	N	135	T
29	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	138	P
30	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	146	H
31	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	147	L
32	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	I/L	Y	158	C
33	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	166	C
34	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	166	H
35	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	182	F
36	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	I/L	S	182	Y
37	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	186	N
38	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	I/L	N	187	D
39	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	N	187	K
40	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	I/L	S	191	P
41	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	I/L	T	211	I
42	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	I/L	V	216	G
43	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	219	T
44	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	W	225	R
45	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	229	L
46	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	I/L	E	237	K
47	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	251	I
48	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	251	V
49	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	261	P
50	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	270	P
51	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	284	N
52	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	291	P
53	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	E	302	K
54	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	I/L	S	349	P
55	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	I/L	R	359	Q
56	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	365	P
57	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	D	366	H
58	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	H	369	R
59	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	380	R
60	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	I/L	A	382	T
61	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	I/L	A	384	P
62	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	I/L	A	384	S
63	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	I/L	A	387	V
64	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	I/L	G	392	D
65	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	I/L	R	393	C
66	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	I/L	R	393	H
67	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	I/L	R	393	P
68	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	I/L	S	394	L
69	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	C
70	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	L
71	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	S
72	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	I	A	404	T
73	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	N	405	K
74	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	406	G
75	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	406	M
76	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	407	A
77	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	I/L	P	407	L
78	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	407	T
79	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	409	P
80	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	421	T
81	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	G	424	R
82	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	425	T
83	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	I/L	A	427	D
84	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	I/L	P	429	L
85	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (81, 81)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	L	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	L	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	L	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	L	R	24	C
05	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	L	R	47	C
06	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	L	R	47	H
07	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	L	R	47	S
08	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	L	R	57	C
09	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	L	F	58	L
10	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	L	Y	63	C
11	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	L	Y	63	S
12	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	L	L	66	P
13	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	L	P	80	T
14	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	L	M	89	K
15	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	L	G	93	D
16	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	L	C	95	R
17	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	L	L	99	F
18	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	L	L	99	V
19	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	L	Q	101	K
20	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	L	K	114	E
21	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	L	T	115	A
22	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	L	S	116	P
23	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	L	Q	118	P
24	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	L	H	120	Y
25	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	L	L	126	P
26	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	L	C	128	Y
27	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	L	R	129	Q
28	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	L	N	135	T
29	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	L	S	138	P
30	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	L	L	146	H
31	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	L	F	147	L
32	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	L	Y	158	C
33	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	L	Y	166	C
34	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	L	Y	166	H
35	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	L	S	182	F
36	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	L	S	182	Y
37	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	L	I	186	N
38	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	L	N	187	D
39	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	L	N	187	K
40	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	L	S	191	P
41	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	L	T	211	I
42	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	L	V	216	G
43	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	L	I	219	T
44	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	L	W	225	R
45	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	L	F	229	L
46	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	L	E	237	K
47	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	L	M	251	I
48	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	L	M	251	V
49	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	L	R	261	P
50	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	L	L	270	P
51	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	L	I	284	N
52	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	L	S	291	P
53	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	L	E	302	K
54	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	L	S	349	P
55	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	L	R	359	Q
56	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	L	S	365	P
57	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	L	D	366	H
58	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	L	H	369	R
59	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	L	S	380	R
60	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	L	A	382	T
61	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	L	A	384	P
62	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	L	A	384	S
63	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	L	A	387	V
64	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	L	G	392	D
65	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	L	R	393	C
66	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	L	R	393	H
67	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	L	R	393	P
68	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	L	S	394	L
73	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	L	N	405	K
74	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	L	R	406	G
75	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	L	R	406	M
76	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	L	P	407	A
77	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	L	P	407	L
78	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	L	P	407	T
79	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	L	L	409	P
80	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	L	I	421	T
81	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	L	G	424	R
82	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	L	R	425	T
83	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	L	A	427	D
84	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	L	P	429	L
85	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	L	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (85, 85)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	I	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	I	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	I	R	24	C
05	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	C
06	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	I	R	47	H
07	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	S
08	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	I	R	57	C
09	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	58	L
10	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	C
11	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	S
12	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	66	P
13	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	80	T
14	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	I	M	89	K
15	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	I	G	93	D
16	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	I	C	95	R
17	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	I	L	99	F
18	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	I	L	99	V
19	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	I	Q	101	K
20	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	I	K	114	E
21	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	I	T	115	A
22	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	I	S	116	P
23	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	I	Q	118	P
24	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	I	H	120	Y
25	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	126	P
26	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	I	C	128	Y
27	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	I	R	129	Q
28	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	I	N	135	T
29	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	138	P
30	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	I	L	146	H
31	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	147	L
32	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	I	Y	158	C
33	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	C
34	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	H
35	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	I	S	182	F
36	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	I	S	182	Y
37	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	186	N
38	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	I	N	187	D
39	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	187	K
40	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	I	S	191	P
41	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	I	T	211	I
42	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	I	V	216	G
43	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	219	T
44	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	I	W	225	R
45	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	229	L
46	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	I	E	237	K
47	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	I
48	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	V
49	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	I	R	261	P
50	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	270	P
51	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	284	N
52	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	291	P
53	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	I	E	302	K
54	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	I	S	349	P
55	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	I	R	359	Q
56	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	365	P
57	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	I	D	366	H
58	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	I	H	369	R
59	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	I	S	380	R
60	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	I	A	382	T
61	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	I	A	384	P
62	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	I	A	384	S
63	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	I	A	387	V
64	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	I	G	392	D
65	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	I	R	393	C
66	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	H
67	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	P
68	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	I	S	394	L
69	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	C
70	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	L
71	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	S
72	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	I	A	404	T
73	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	405	K
74	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	G
75	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	M
76	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	A
77	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	I	P	407	L
78	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	T
79	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	409	P
80	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	421	T
81	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	I	G	424	R
82	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	I	R	425	T
83	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	I	A	427	D
84	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	I	P	429	L
85	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (1, 2)

Exons (6, 12)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain I from PDB  Type:PROTEIN  Length:419
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:432
                                    42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462  
           ANT3_HUMAN    33 HGSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 464
               SCOP domains d2anti_ I: Antithrombin                                                                                                                                                                                                                                                                                                                                                                                                                          SCOP domains
               CATH domains ------------2antI02 I:13-224,             I:321-377 Antithrombin, subunit I, domain 2                                                                                                                                           2antI01 I:225-320,I:383-430 Alpha-1-antitrypsin, domain 1                                       2antI02 I:13-224,I:321-377                               -----2antI01 I:225-320,I:383-430                     -- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .............................-------------......hhhhhhhhhhhhhhhhhhhh.......eee.hhhhhhhhhhhhhh....hhhhhhhh............hhhhhhhhhhhhh.........eeeeeeeeee......hhhhhhhhh....eeeee.hhhhhhhhhhhhhhhhhhhh..................eeeeeeeee.........hhh.eeeeee.....eeeeee...eeeeeeeee...eeeeeee.....eeeeeee......hhhhhhh..hhhhhhhhhh.eeeeeeee...eeeeeeee.hhhhhhh...hhh.......hhh.........eeeeeeeeeeee.........................eee....eeeeeee....eeeeeeee...... Sec.struct. author
             SAPs(SNPs) (1) ------N------------TF--C----------------------C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------- SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     -------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: I:1-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                             Exon 1.4c  PDB: I:105-176 UniProt: 137-208                              Exon 1.5a  PDB: I:177-222 UniProt: 209-254    Exon 1.6b  PDB: I:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: I:375-432 UniProt: 407-464                 Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             ---------------------------------------------------------- Transcript 1 (2)
                 2ant I   1 HGSPVDICTAKPRDIPMNPMCIYRSPEKK-------------ATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 432
                                    10        20        |-         -  |     50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430  
                                                       29            43

Chain L from PDB  Type:PROTEIN  Length:398
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:426
                                    48        58        68        78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308       318       328       338       348       358       368       378       388       398       408       418       428       438       448       458      
           ANT3_HUMAN    39 ICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 464
               SCOP domains d2ant  l_ L: Antith                 rombin                                                                                                                                                                                                                                                                                                                                                                                                 SCOP domains
               CATH domains ----2  antL02 L:11-                 224,L:321-377 Antithrombin, subunit I, domain 2                                                                                                                                       2antL01 L:225-320,L:378-429 Alpha-1-antitrypsin, domain 1                                       2antL02 L:11-224,L:321-377                               2antL01 L:225-320,         L:378-429                --- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .....--............-----------------..hhhhhhhhhhhhhhhhhhhhhhhhh......eee.hhhhhhhhhhhhhh....hhhhhhhh..hhh.....hhhhhhhhhhhhhhhh......eeeeeeeee.........hhhhhhhhhh.........hhhhhhhhhhhhhhhhhhh....................eeeeeeeeeee..........eeeeee.....eeeeeeeeeeeeeeeee.hhh.eeeeee.....eeeeeee......hhhhhhh..hhhhhhhhhh.eeeeeeeeee.eeeeeeee.hhhhhh....hhh...................eeeeeeeeeeee...eeeeeeeeeeee.....---------....eeeeee....eeeeeee....... Sec.struct. author
             SAPs(SNPs) (1) N------------TF--C----------------------C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL----------KGA-P-----------T--RT-D-LF-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H------------ML------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P-------------T------------------------- SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     -------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: L:7-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                       Exon 1.4c  PDB: L:105-176 UniProt: 137-208                              Exon 1.5a  PDB: L:177-222 UniProt: 209-254    Exon 1.6b  PDB: L:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: L:375-432 (gaps) UniProt: 407-464          Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             ---------------------------------------------------------- Transcript 1 (2)
                 2ant L   7 ICTAK--DIPMNPMCIYRS-----------------ATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSL---------NRPFLVFIREVPLNTIIFMGRVANPCVK 432
                                |  |16        |-         -      | 46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386        |-       406       416       426      
                               11 14         25                43                                                                                                                                                                                                                                                                                                                                                             395       405

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (2, 4)

Pfam Domains (0, 0)

Gene Ontology (17, 17)

Asymmetric Unit(hide GO term definitions)

Chain I,L (ANT3_HUMAN | P01008)

molecular function
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030414	peptidase inhibitor activity	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004867	serine-type endopeptidase inhibitor activity	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0010951	negative regulation of endopeptidase activity	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0010466	negative regulation of peptidase activity	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
	GO:2000266	regulation of blood coagulation, intrinsic pathway	Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 2)

Sites (2, 2)

SS Bonds (6, 6)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (85, 166)

PROSITE Motifs (1, 2)

Exons (6, 12)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (2, 4)

Pfam Domains (0, 0)

Gene Ontology (17, 17)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File